Search - tctmd.com

Displaying 21 - 40 of 193

Sort: Relevancy | Date

New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO

News Daily News

New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO

November 30, 2023

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

News Daily News

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

Michael O'Riordan

November 27, 2023

One-Third of Patients With AF After Surgery or Illness Have Recurrences

News Daily News

One-Third of Patients With AF After Surgery or Illness Have Recurrences

Michael O'Riordan

October 02, 2023

Etripamil Continues to Show Promise in Paroxysmal SVT: NODE-302

News Daily News

Etripamil Continues to Show Promise in Paroxysmal SVT: NODE-302

September 27, 2023

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

September 18, 2023

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

September 13, 2023

Early Cognitive Dysfunction After AF Ablation Doesn’t Last

News Daily News

Early Cognitive Dysfunction After AF Ablation Doesn’t Last

July 25, 2023

Off-label DOAC Dosing Tied to Worse Adherence, More Discontinuation

News Daily News

Off-label DOAC Dosing Tied to Worse Adherence, More Discontinuation

June 14, 2023

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

News Daily News

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

June 05, 2023

Generic Dabigatran Lots Pulled for Nitrosamine Impurity

News Daily News

Generic Dabigatran Lots Pulled for Nitrosamine Impurity

Michael O'Riordan

March 28, 2023

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

News Daily News

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

March 15, 2023

LAAO Tops Oral Anticoagulation for AF in Women and Men: Medicare Analysis

News Daily News

LAAO Tops Oral Anticoagulation for AF in Women and Men: Medicare Analysis

February 24, 2023

Top Heart Rhythm News of 2022

News Daily News

Top Heart Rhythm News of 2022

January 05, 2023

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

News Daily News

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

November 23, 2022

Apixaban Again Linked to Less Bleeding in AF Patients

News Daily News

Apixaban Again Linked to Less Bleeding in AF Patients

Michael O'Riordan

October 31, 2022

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

RAPID: Positive Top-line Results for Etripamil Nasal Spray in Paroxysmal SVT

News Daily News

RAPID: Positive Top-line Results for Etripamil Nasal Spray in Paroxysmal SVT

October 17, 2022

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

October 12, 2022

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

News Daily News

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

September 26, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.